First Solar, Inc. (FSLR) Stock Price Today
Phase II study shows Vilamakitug improves 12-month survival in refractory metastatic colorectal cancer.
XBiotech announced positive final results from the Phase II TASKIN study, showing that adding Vilamakitug (XB2001) to standard chemotherapy improved 12-month overall survival to 61.3% in patients with refractory metastatic colorectal cancer, surpassi...
Socialism gains political ground in US, prompting free market advocates to strengthen their case for capitalism.
Socialism is rising in popularity within U.S. politics, particularly among those identifying as democratic socialists who seek a system more like European social democracy. Sam Gregg of the American Institute for Economic Research highlights the need...
BHP plans major underground expansion at Olympic Dam using block cave mining.
BHP is preparing for a multi-billion-dollar underground expansion at its Olympic Dam copper mine in South Australia, using block cave mining to access more ore. This method allows cost-effective extraction of lower-grade ore by letting the rock above...
NYCB shareholders can pursue claims after judge denies motion to dismiss over alleged governance issues.
New York Community Bank Bancorp (NYCB) faces shareholder claims after a federal judge denied a motion to dismiss allegations that the bank misled investors about governance and loan asset quality. The issues include non-compliance with enhanced prude...
Hershey Trust sells shares ahead of Q3 earnings, retaining control amid price hikes and volume drop.
The Hershey Trust Company sold 1,512 common shares under a trading plan but kept voting control through Class B shares. Hershey will report Q3 earnings on October 29, with investors focused on how price increases affected Halloween-season demand. Q2 ...
Silence Therapeutics jumps 125% after $1.3B acquisition deal with Merck KGaA
Silence Therapeutics' stock surged 125.6% to $19.58 following Merck KGaA's agreement to acquire the RNA-interference drug developer for about $1.3 billion in equity value. Merck will pay $20 per share, a 130% premium over the recent closing price. Ot...
Stocks tumble as Iambic Therapeutics and TCGX Acquisition lead losses amid IPO and merger news.
On October 19, 2026, several stocks saw significant declines. Iambic Therapeutics dropped 31.4% but stayed just above its IPO price of $16 after raising $150 million. TCGX Acquisition fell 18.5% following its announcement of a merger with TriGemX Bio...
Broadcom signs 10-year deal to advance NTT DOCOMO's private cloud with VMware technology
Broadcom has entered a 10-year agreement with NTT DOCOMO to enhance the telecom's private cloud infrastructure using VMware Cloud Foundation. This deal, Broadcom Japan's first long-term VMware software agreement, aims to improve service reliability, ...
Solis Minerals launches 5,000m drilling at Peru's Cucho Copper Project targeting large copper-molybdenum system.
Solis Minerals is starting a 5,000-metre diamond drilling program at its Cucho Copper Project in Peru, focusing on three priority zones within an expanding copper-molybdenum system. Recent geological work has extended the target area and identified a...
Trading resumes for GoldCoast Resource Corp. on Canadian markets after regulatory halt.
Trading in all issues of GoldCoast Resource Corp. (symbol GCR) has resumed at 8:00 AM ET following a temporary halt imposed by the Canadian Investment Regulatory Organization (CIRO). Such halts are used to maintain fair and orderly markets. CIRO over...
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.